发明名称 Vaccine composition
摘要 <p>The present invention relates to virus vectors comprising oligonucleotides encoding HIV polypeptides, more particularly wherein the virus vector is an adenovirus. In particular, such adenoviruses are non-human primate adenoviruses such as simian adenoviruses, more particularly chimpanzee adenoviruses. In particular the invention relates to adenovirus vectors which comprise HIV polynucleotide sequences which encode multiple different HIV antigens, for example two or three or more HIV antigens. The invention further relates to methods of preparing the virus vectors, to the virus vectors produced by the methods and to the use of the vectors in medicine especially prophylactic or therapeutic vaccination.</p>
申请公布号 IL186828(A) 申请公布日期 2015.06.30
申请号 IL20070186828 申请日期 2007.10.22
申请人 GLAXO GROUP LIMITED 发明人
分类号 A61K;C07K;C12N 主分类号 A61K
代理机构 代理人
主权项
地址